BERLIN--(BUSINESS WIRE)--Booster Therapeutics, a biotechnology company pioneering a new class of proteasome activator medicines to treat neurodegenerative and other diseases, launched today with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback